26.3 C
Kuala Lumpur
Saturday, September 21, 2019

Tag: pharmaceuticals

Bayer sells Dr Scholl’s for US$585 mil

The Boston private equity firm Yellow Wood Partners will pay US$585 million for Bayer's Doctor Scholl's business, which generated US$234 million in revenues last year.

Eli Lilly to acquire Loxo Oncology for US$8 billion

The deal - which represents a premium of some 68% over Loxo Oncology's closing share price on Friday - is expected to close by the end of the first quarter.

Drugmaker Bristol-Myers Squibb to buy Celgene in US$74 billion deal

Celgene shareholders will receive one Bristol-Myers Squibb share along with US$50 in cash for each Celgene share.

Whistleblower rues silence over report of graft in medicine supplies

It's been four months since he told the health ministry about politically connected firms raking in billions as tendering agents.

Treatment for rare diseases: We need to do better

When and where treatments exist, they are often expensive and place enormous financial strain on households and health systems.

Santiago calls for review of medicine tender system

DAP's Klang MP says prices may be artifically high if whistleblower's bombshell account about tenders being rigged is true.

Brexit trade threat prompts retail, pharma workaround plans

U.S. pharmaceutical giant Merck & Co. is planning for the possibility of a temporary supply blackout when the U.K. leaves the European Union and may stockpile as much as six months worth of goods and revise trade routes in preparation.

STUDY: Rivers worldwide threatened by pharma waste

River systems around world are coursing with over-the-counter and prescription drug waste harmful to the environment, researchers said Tuesday.

IP protection: Naysayers are wrong, says Ideas

'There's no evidence to support the allegation that intellectual property protection will adversely affect healthcare.'

Unregistered medicines, cosmetics worth RM263K seized

Kelantan health authorities find 33 Facebook pages and Instagram accounts advertising medical products without prior approval from the Medicine Advertisements Board, which is an offence under the Medicines (Advertisement and Sale) Act 1956.

Archived: Brunei aims to be halal pharma hub

Brunei has also developed its very own guidelines and standards for the handling and manufacturing of halal pharmaceutical products.

TPPA meet ‘narrowed differences’

The negotiating groups are exploring further options on challenging subjects of intellectual property, environment and state-owned enterprises.

Archived: ‘Docs in cahoots with drug firms’

You may be paying your clinic too much for your medicine, and you may not even need it.